.In 2010, neuroscientist as well as previous Eli Lilly research leader Steve Paul started a firm that he wished would stimulate a rotation in medication discovery developed around a course of compounds dubbed neurosteroids that can aid soothe overactive mind circuits and also fire up sleepy ones for a lengthy list of psychiatric and nerve disorders.